While AT2R and MasR have been implicated in EMT in CRC and ovarian cancers [63, 69], AT1R appears to have a more significant role in ovarian cancer, where its overexpression significantly increased migration [49]. This evidence concerns the gene MAS1L and ovarian cancer.